Lacer S.A. is a prominent Spanish pharmaceutical company with over 70 years of history, known for its strong presence in both prescription medicines and consumer health products, especially in oral hygiene. The company was acquired by the Italian multinational Italfarmaco Group in July 2022.

Company Profile

Official Name:
LACER, S.A.

Ownership:
Wholly owned subsidiary of the Italfarmaco Group.

Headquarters:
Barcelona, Spain.

Industrial Facilities:
State-of-the-art plant in the Parc Tecnològic del Vallès in Cerdanyola del Vallès, Barcelona.

Focus:
Research, development, and marketing of innovative products to improve human health and quality of life.

International Presence:
Products are available in more than 20 countries, with a strong presence in Europe and Latin America.

Product Areas and Key Brands

Lacer operates in several therapeutic areas, combining a strong pharmaceutical pipeline with market-leading personal care brands available primarily through pharmacies.

Oral Health (Dental Hygiene):
A market leader in Spain.

Gingilacer:
Products designed to reduce gum bleeding and plaque formation.

Lacer Oros:
Comprehensive protection for teeth and gums, addressing sensitivity and caries prevention.

Clorhexidina Lacer:
Leading antiseptic products for treating periodontal diseases (gingivitis and periodontitis).

Sensilacer:
Products providing rapid relief from tooth sensitivity.

Lacer Blanc:
A range of whitening toothpastes and kits.

Dermo-cosmetics and Personal Care:

Pilexil:
A leading brand for hair loss treatments and shampoos.

Talquistina:
Products for soothing itchy, irritated skin.

Anso:
Products for treating specific conditions like hemorrhoids.

Prescription Medicines:
The company is a market leader in cardiovascular products within Spain. They also have medicines in urology, gynaecology, and musculoskeletal health.

Medical Devices:
Includes products for blood pressure measurement and cholesterol control.